lobbying_activities: 1144997

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1144997	fcf3143c-2dfe-4923-b18f-ad5e7bdcfd99	Q3	THE GIBSON GROUP, LLC	400703107	ENDO PHARMACEUTICALS INC.	2011	third_quarter	HCR	S. 319 - Pharmaceutical Market Access and Drug Safety Act of 2011 Issues relating to bioequivalence and related administrative procedures Issues relating to DEA quotas for controlled substances	HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE	30000		0	0	2011-10-05T14:31:46.803000-04:00